Elizabeth Holmes's Partner Ventures into Blood-Testing
Billy Evans, connected to Elizabeth Holmes, the infamous Theranos founder now serving time for fraud, has embarked on a fresh endeavor in the realm of blood-testing start-ups.
A New Venture with Big Promises
While Elizabeth Holmes is incarcerated for deceiving investors with Theranos's ambitious but misleading claims, her companion, Billy Evans, is venturing into diagnostics in the hopes of securing funds for his company.
Evans, who shares two children with Holmes, is attempting to gather investment for an enterprise that brands itself as 'the future of diagnostics' and offers 'a revolutionary method for health assessments,' according to promotional documents.
Echos of Theranos's Vision
The premise of Evans's company might sound reminiscent of Theranos, which previously garnered international interest by falsely promoting its technology as capable of conducting extensive laboratory testing with only a tiny sample of blood.
Introducing Haemanthus
Evans's enterprise is named Haemanthus, inspired by the blood lily flower. Initially, it aims to conduct diagnostic tests on animals, with a long-term goal of expanding to human testing, according to two anonymous investors privy to confidential pitches.
Raising Capital and Building Machines
Evans aims to eventually attract investment exceeding $50 million, with the overarching goal being the optimization of human health. A prototype image presented to investors shows a device strikingly similar to Theranos's controversial machines, which were dubbed Edison or miniLab.
The current prototype described in investor materials features a boxy design, equipped with a digital interface and adjustable lasers within its structure.




Leave a Reply